QTTB Stock Analysis: Buy, Sell, or Hold?
QTTB - Q32 Bio Inc. Common Stock
$13.17
1.22 (10.21%)
▲
5d:
+10.67%
30d:
+2.49%
90d:
+84.45%
HOLD
MODERATE Confidence
Analysis Updated: Jun 26, 2026 12:00 AM ET
Earnings: Aug 05, 2026
Get Alerted When QTTB Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: QTTB shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: QTTB shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: QTTB is currently trading at $13.17, which is considered slightly high relative to its 30-day fair value range of $8.59 to $13.72.
Technical Outlook: Technically, QTTB is in a uptrend. Immediate support is located at $9.15, while resistance sits at $14.85. The stock is showing strong short-term momentum, up 10.2% recently.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Implied Volatility is high (99th percentile), indicating expensive options premiums. This environment often favors selling options or covered calls to generate income. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, QTTB is in a uptrend. Immediate support is located at $9.15, while resistance sits at $14.85. The stock is showing strong short-term momentum, up 10.2% recently.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Implied Volatility is high (99th percentile), indicating expensive options premiums. This environment often favors selling options or covered calls to generate income. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$8.59 -
$13.72
Company Quality Score
50/100
(HOLD)
Options IV Signal
99th percentile
(ELEVATED)
Volume Confirmation
HIGH
Confidence Score
52.9%
All Signals
- BEARISH: Options expensive (IV 99th percentile)
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+10.2%)
- NEUTRAL: Near Wall St target ($14.25)
Trading Range Analysis
30-Day Trading Range
$8.59 -
$13.72
Current vs Trading Range
SLIGHTLY HIGH
Expected Move (7 Days)
±$3.54
(26.9%)
Support & Resistance Levels
Support Level
$9.15
Resistance Level
$14.85
Current Trend
Uptrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-5.91
Wall Street Target
$14.25
(+8.2%)
Profit Margin
61.9%
Share & Embed Analysis
Last updated: June 27, 2026 7:13 PM ET
Data refreshes hourly during market hours. Next update: 8:13 PM
Data refreshes hourly during market hours. Next update: 8:13 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is QTTB showing a specific setup today?
Insider Activity (6 Months)
0
Buys
3
Sells
Net
INSIDERS SELLING
Recent Transactions
Jodie Pope Morrison
SELL
9896 shares
2026-02-25
Lee Kalowski
SELL
3995 shares
2026-02-25
Shelia M Violette
SELL
2815 shares
2026-02-25
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$88 | 64 BUY |
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
30 analysts |
$436 | 60 BUY |
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$549 | 67 BUY |
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$58 | 54 HOLD |
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$84 | 58 HOLD |
